Global specialty, generic and consumer healthcare medicines company STADA and Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and ...
Launch preparations are underway to bring the second approved golimumab biosimilar to patients across Europe in the coming weeks and months Bio-Thera is responsible for development, manufacture and ...
The old facility, across the street, had only6 beds. The new one has 10. This story has been updated to add new information. HENDERSONVILLE – UNC Health Pardee has expanded its capacity to give ...
For people living with primary immunodeficiency (PI), immunoglobulin replacement therapy is an essential part of preventing serious infections. The treatment can be delivered through an IV ...
If you’re anything like me, you’ve likely learned to approach new beauty launches with a healthy dose of skepticism—especially those that promise overnight results or claim to replicate pricey ...
As employers look for new ways to make their healthcare benefits as effective and affordable as possible, two companies have partnered to bring infusion care closer to home. Processing Content ...
Come renewal season, employers tend to focus their health benefit strategies on the usual suspects: increasing costs of prescription drugs, chronic health conditions like cancer and diabetes, and the ...
Ambulatory infusion care has moved from a niche alternative to a cornerstone of chronic disease management. A decade ago, most infusions occurred in hospital outpatient departments (HOPDs) where ...
Infusion therapy is a lifeline for people living with autoimmune disorders and chronic conditions. It’s also frequently associated with cold hospital rooms and crushing financial stress. But two ...
At many health systems, infusion services operate across multiple sites with varying workflows and approval processes. At Cone Health, based in Greensboro, N.C., pharmacy leaders have spent the past ...
In tandem with methotrexate, the drug is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis. Availability across EEA markets will progress in line ...
Pharmacy providers are increasingly moving into the infusion space – either standing up ambulatory infusion suites (“AIS”) or proving home infusion delivery models – despite unclear licensure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results